Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis
- PMID: 28771572
- PMCID: PMC5542468
- DOI: 10.1371/journal.pone.0182488
Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis
Abstract
Objective: The aim of this meta-analysis was to determine the efficacy and safety of glyburide as a treatment for gestational diabetes mellitus (GDM) compared to insulin.
Methods: A meta-analysis was conducted to compare the management of gestational diabetes with glyburide and insulin. Studies fulfilling all of the following inclusion criteria were included in this meta-analysis: subjects were women with gestational diabetes requiring drug treatment; the comparison treatment included glyburide vs insulin; one or more outcomes (maternal or neonatal) should be provided in the individual study; the study design should be a randomized control trial. Exclusion criteria: non-RCT studies; non-human data. PubMed, Embase and CENTRAL databases were searched from inception until 10 October 2016.
Results: Ten randomized control trials involving 1194 participants met the inclusion criteria and were included. 13 primary outcomes (6 maternal, 7 neonatal) and 26 secondary outcomes (9 maternal, 17 neonatal) were detected and analyzed in this study. Glyburide significantly increased the risk of any neonatal hypoglycemia [risk ratio (RR), 1.89; 95% confidence interval (95%CI), 1.26 to 2.82; p = 0.002]. Sensitivity analysis confirmed robustness of this result [RR, 2.29; 95%CI, 1.49 to 3.54; p = 0.0002]. No differences were observed between the two groups with respect to birth weights [mean difference (MD), 79; 95%CI, -64 to 221.99; p = 0.28] and the risk of macrosomia [RR, 1.69; 95%CI, 0.57 to 5.08; p = 0.35].
Conclusion: For women with gestational diabetes, no differences in maternal short term outcomes were observed in those treated with glyburide or insulin. However, the incidence of neonatal hypoglycemia was higher in the glyburide group compared to the insulin group.
Conflict of interest statement
Figures
Similar articles
-
Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis.J Diabetes Res. 2019 Nov 4;2019:9804708. doi: 10.1155/2019/9804708. eCollection 2019. J Diabetes Res. 2019. PMID: 31781670 Free PMC article.
-
Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes.Ann Pharmacother. 2008 Apr;42(4):483-90. doi: 10.1345/aph.1K577. Epub 2008 Mar 18. Ann Pharmacother. 2008. PMID: 18349305
-
Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes.JAMA Pediatr. 2015 May;169(5):452-8. doi: 10.1001/jamapediatrics.2015.74. JAMA Pediatr. 2015. PMID: 25822253
-
The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis.Adv Med Sci. 2014 Mar;59(1):95-101. doi: 10.1016/j.advms.2014.03.001. Epub 2014 Mar 22. Adv Med Sci. 2014. PMID: 24797983
-
Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.J Perinatol. 2007 May;27(5):262-7. doi: 10.1038/sj.jp.7211683. Epub 2007 Mar 15. J Perinatol. 2007. PMID: 17363911
Cited by
-
Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis.J Diabetes Res. 2019 Nov 4;2019:9804708. doi: 10.1155/2019/9804708. eCollection 2019. J Diabetes Res. 2019. PMID: 31781670 Free PMC article.
-
The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.Curr Diab Rep. 2019 Dec 6;19(12):158. doi: 10.1007/s11892-019-1243-1. Curr Diab Rep. 2019. PMID: 31811400 Free PMC article. Review.
-
Risk of hypoglycemia by anthropometric measurements in neonates of mothers with diabetes.Eur J Pediatr. 2022 Sep;181(9):3483-3490. doi: 10.1007/s00431-022-04532-6. Epub 2022 Jul 4. Eur J Pediatr. 2022. PMID: 35789293
-
Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.JAMA. 2018 May 1;319(17):1773-1780. doi: 10.1001/jama.2018.4072. JAMA. 2018. PMID: 29715355 Free PMC article. Clinical Trial.
-
Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis.BMC Endocr Disord. 2021 Oct 12;21(1):199. doi: 10.1186/s12902-021-00865-9. BMC Endocr Disord. 2021. PMID: 34641848 Free PMC article.
References
-
- Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010;203(5):457.e1–9. - PubMed
-
- American Diabetes Association. Erratum. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S13-S22. Diabetes care. 2016;39(9):1653 doi: 10.2337/dc16-er09 - DOI - PubMed
-
- Gupta Y, Kalra B, Baruah MP, Singla R, Kalra S. Updated guidelines on screening for gestational diabetes. Int J Womens Health. 2015;7:539–50. doi: 10.2147/IJWH.S82046 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous